244 related articles for article (PubMed ID: 32498919)
1. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
Pan JA; Kerwin MJ; Salerno M
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
3. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
[TBL] [Abstract][Full Text] [Related]
4. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
[TBL] [Abstract][Full Text] [Related]
5. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
6. Regional amyloid distribution and impact on mortality in light-chain amyloidosis: a T1 mapping cardiac magnetic resonance study.
Wan K; Li W; Sun J; Xu Y; Wang J; Liu H; Dong Y; Cheng W; Zhang Q; Zeng Z; Zhou X; Han Y; Chen Y
Amyloid; 2019 Mar; 26(1):45-51. PubMed ID: 30931628
[TBL] [Abstract][Full Text] [Related]
7. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
[TBL] [Abstract][Full Text] [Related]
8. A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.
Chamling B; Bietenbeck M; Drakos S; Korthals D; Vehof V; Stalling P; Meier C; Yilmaz A
Sci Rep; 2022 Dec; 12(1):21755. PubMed ID: 36526658
[TBL] [Abstract][Full Text] [Related]
9. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
[TBL] [Abstract][Full Text] [Related]
10. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of native T1 and extracellular volume in patients with immunoglubin light-chain amyloidosis.
Liu Y; Wang L; Zhu J; Chen M; Zhu M; Dai Y; Hu C
BMC Cardiovasc Disord; 2024 Feb; 24(1):112. PubMed ID: 38365569
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis.
Briasoulis A; Lama N; Rempakos A; Theodorakakou F; Stamatelopoulos K; Dimopoulos MA; Kelekis N; Kastritis E
Curr Probl Cardiol; 2023 Apr; 48(4):101573. PubMed ID: 36586704
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.
Oda S; Utsunomiya D; Morita K; Nakaura T; Yuki H; Kidoh M; Hirata K; Taguchi N; Tsuda N; Shiraishi S; Namimoto T; Hirakawa K; Takashio S; Izumiya Y; Yamamuro M; Hokimoto S; Tsujita K; Ueda M; Yamashita T; Ando Y; Yamashita Y
Eur Radiol; 2017 Nov; 27(11):4631-4638. PubMed ID: 28477167
[TBL] [Abstract][Full Text] [Related]
15. 3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis.
Liu Y; Zhu J; Chen M; Wang L; Zhu M; Weng Z; Hu C
Ann Transl Med; 2022 Jul; 10(14):794. PubMed ID: 35965812
[TBL] [Abstract][Full Text] [Related]
16. Reference Ranges, Diagnostic and Prognostic Utility of Native T1 Mapping and Extracellular Volume for Cardiac Amyloidosis: A Meta-Analysis.
Wang TKM; Brizneda MV; Kwon DH; Popovic ZB; Flamm SD; Hanna M; Griffin BP; Xu B
J Magn Reson Imaging; 2021 May; 53(5):1458-1468. PubMed ID: 33274809
[TBL] [Abstract][Full Text] [Related]
17. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance.
Martini N; Aimo A; Barison A; Della Latta D; Vergaro G; Aquaro GD; Ripoli A; Emdin M; Chiappino D
J Cardiovasc Magn Reson; 2020 Dec; 22(1):84. PubMed ID: 33287829
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
[TBL] [Abstract][Full Text] [Related]
19. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
